Spaventa Andrew's Form 4 filing
Singular Genomics Systems, Inc.OMIC · filed Feb 14, 2025
- Accession no.
- 0000950170-25-021402
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $15.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spaventa AndrewCIK 0001859701 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +1,907 | –F1 | – | 2,232 | Direct | |
| Feb 14, 2025 | Common Stock | SSaleDisposed | −800 | $19.89F3 | −$15,912 | 1,432 | Direct | |
| Feb 14, 2025 | Common Stock | GGiftDisposed | −1,107 | $0.00 | $0 | 325 | Direct | |
| Feb 14, 2025 | Common Stock | GGiftAcquired | +1,107 | $0.00 | $0 | 142,900 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −1,907 | $0.00 | $0 | 22,873 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.
- F3
Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $19.88 to $19.91, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.